Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Franchini

Showing results (151-160 of 297) with videos related to

Pageof 30
Sort By:
Cellular and Molecular Biology (Noisy-Le-Grand, France)|January 1, 1995
Molecular phylogeny and dissemination of human T-cell lymphotropic virus type I viewed within the context of primate evolution and human migrationR Yanagihara, N Saitou, V R Nerurkar, et al.
Water Research|January 16, 2010
Aerated treatment pond technology with biofilm promoting mats for the bioremediation of benzene, MTBE and ammonium contaminated groundwaterSven Jechalke, Carsten Vogt, Nils Reiche, et al.
Virology|August 8, 2021
Lentiviral transduction of neonatal rat ventricular myocytes preserves ultrastructural features of genetically modified cellsSílvio R Consonni, Anna C P V de Carvalho, Artur B Mauro, et al.
Virology|August 11, 2000
The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbitsG A Dekaban, A A Peters, J C Mulloy, et al.
Blood|September 1, 1996
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cellsA Cereseto, F Diella, J C Mulloy, et al.
Oncogene|August 12, 1999
Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I)V Ciminale, L Zotti, D M D'Agostino, et al.
Journal of Virology|June 8, 2001
Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) proteinJ M Johnson, C Nicot, J Fullen, et al.
Blood|June 14, 2000
p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cellsS Takemoto, R Trovato, A Cereseto, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1992
[HTLV-I retroviral variant in Zaire in patient with chronic neuromyelopathy. Nucleotidic sequence of the envelope gene]A Gessain, E Boeri, K Kazadi, et al.
Journal of Cardiac Failure|April 21, 2006
Left ventricular reconstruction brings benefit for patients with ischemic cardiomyopathyGustavo C Aguiar Ribeiro, Fernando Antoniali, Mauricio M Lopes, et al.
Pageof 30

Showing results (151-160 of 297) with videos related to

Sort By:
Pageof 30
Cellular and Molecular Biology (Noisy-Le-Grand, France)|January 1, 1995
Molecular phylogeny and dissemination of human T-cell lymphotropic virus type I viewed within the context of primate evolution and human migrationR Yanagihara, N Saitou, V R Nerurkar, et al.
Water Research|January 16, 2010
Aerated treatment pond technology with biofilm promoting mats for the bioremediation of benzene, MTBE and ammonium contaminated groundwaterSven Jechalke, Carsten Vogt, Nils Reiche, et al.
Virology|August 8, 2021
Lentiviral transduction of neonatal rat ventricular myocytes preserves ultrastructural features of genetically modified cellsSílvio R Consonni, Anna C P V de Carvalho, Artur B Mauro, et al.
Virology|August 11, 2000
The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbitsG A Dekaban, A A Peters, J C Mulloy, et al.
Blood|September 1, 1996
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cellsA Cereseto, F Diella, J C Mulloy, et al.
Oncogene|August 12, 1999
Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I)V Ciminale, L Zotti, D M D'Agostino, et al.
Journal of Virology|June 8, 2001
Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) proteinJ M Johnson, C Nicot, J Fullen, et al.
Blood|June 14, 2000
p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cellsS Takemoto, R Trovato, A Cereseto, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1992
[HTLV-I retroviral variant in Zaire in patient with chronic neuromyelopathy. Nucleotidic sequence of the envelope gene]A Gessain, E Boeri, K Kazadi, et al.
Journal of Cardiac Failure|April 21, 2006
Left ventricular reconstruction brings benefit for patients with ischemic cardiomyopathyGustavo C Aguiar Ribeiro, Fernando Antoniali, Mauricio M Lopes, et al.
Pageof 30